Literature DB >> 14706423

Possible association between a haplotype of the GABA-A receptor alpha 1 subunit gene (GABRA1) and mood disorders.

Yasue Horiuchi1, Junko Nakayama, Hiroki Ishiguro, Tsuyuka Ohtsuki, Sevilla D Detera-Wadleigh, Tomoko Toyota, Kazuo Yamada, Masahiro Nankai, Haruo Shibuya, Takeo Yoshikawa, Tadao Arinami.   

Abstract

BACKGROUND: The gamma-aminobutyric acid (GABA) neurotransmitter system has been implicated in the pathogenesis of mood disorders. The GABRA1 gene encodes one of the subunits of GABA-A receptor and is located on human chromosome 5q34-q35, which is a region reportedly linked to mood disorders. We examined the GABRA1 gene as a candidate for mood disorders.
METHODS: We performed mutation screening of GABRA1 in 24 Japanese bipolar patients and evaluated associations in Japanese case-control subjects consisting of 125 patients with bipolar disorder, 147 patients with depressive disorders, and 191 healthy control subjects. Associations were confirmed in the National Institute of Mental Health (NIMH) Initiative Bipolar Pedigrees, which consists of 88 multiplex pedigrees with 480 informative persons.
RESULTS: We identified 13 polymorphisms in the GABRA1 gene. Nonsynonymous mutations were not found. Association of a specific haplotype with affective disorders was suggested in the Japanese case-control population (corrected p=.0008). This haplotype association was confirmed in the NIMH pedigrees (p=.007).
CONCLUSIONS: These results indicate that the GABRA1 gene may play a role in the etiology of bipolar disorders.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14706423     DOI: 10.1016/s0006-3223(03)00689-9

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  13 in total

1.  The GABAergic deficit hypothesis of major depressive disorder.

Authors:  B Luscher; Q Shen; N Sahir
Journal:  Mol Psychiatry       Date:  2010-11-16       Impact factor: 15.992

Review 2.  GABA(A) receptors and their associated proteins: implications in the etiology and treatment of schizophrenia and related disorders.

Authors:  Erik I Charych; Feng Liu; Stephen J Moss; Nicholas J Brandon
Journal:  Neuropharmacology       Date:  2009-07-23       Impact factor: 5.250

3.  Deciphering diseases and biological targets for environmental chemicals using toxicogenomics networks.

Authors:  Karine Audouze; Agnieszka Sierakowska Juncker; Francisco J S S A Roque; Konrad Krysiak-Baltyn; Nils Weinhold; Olivier Taboureau; Thomas Skøt Jensen; Søren Brunak
Journal:  PLoS Comput Biol       Date:  2010-05-20       Impact factor: 4.475

4.  Polymorphisms in the GRIA1 gene region in psychotic bipolar disorder.

Authors:  Berit Kerner; Anna J Jasinska; Joseph DeYoung; Maricel Almonte; Oi-Wa Choi; Nelson B Freimer
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2009-01-05       Impact factor: 3.568

Review 5.  α2-containing GABA(A) receptors: a target for the development of novel treatment strategies for CNS disorders.

Authors:  Elif Engin; Jing Liu; Uwe Rudolph
Journal:  Pharmacol Ther       Date:  2012-08-18       Impact factor: 12.310

6.  Loss of divalent metal transporter 1 function promotes brain copper accumulation and increases impulsivity.

Authors:  Murui Han; JuOae Chang; Jonghan Kim
Journal:  J Neurochem       Date:  2016-07-22       Impact factor: 5.372

7.  Adolescent THC exposure in female rats leads to cognitive deficits through a mechanism involving chromatin modifications in the prefrontal cortex.

Authors:  Pamela Prini; Franceso Rusconi; Erica Zamberletti; Marina Gabaglio; Federica Penna; Mauro Fasano; Elena Battaglioli; Daniela Parolaro; Tiziana Rubino
Journal:  J Psychiatry Neurosci       Date:  2017-10-12       Impact factor: 6.186

Review 8.  Depression and antidepressants: molecular and cellular aspects.

Authors:  Cristina Lanni; Stefano Govoni; Adele Lucchelli; Cinzia Boselli
Journal:  Cell Mol Life Sci       Date:  2009-06-12       Impact factor: 9.261

9.  Convergent functional genomic studies of ω-3 fatty acids in stress reactivity, bipolar disorder and alcoholism.

Authors:  H Le-Niculescu; N J Case; L Hulvershorn; S D Patel; D Bowker; J Gupta; R Bell; H J Edenberg; M T Tsuang; R Kuczenski; M A Geyer; Z A Rodd; A B Niculescu
Journal:  Transl Psychiatry       Date:  2011-04-26       Impact factor: 6.222

10.  Do motor control genes contribute to interindividual variability in decreased movement in patients with pain?

Authors:  Bikash K Mishra; Tianxia Wu; Inna Belfer; Colin A Hodgkinson; Leonardo G Cohen; Carly Kiselycznyk; Albert Kingman; Robert B Keller; Qiaoping Yuan; David Goldman; Steven J Atlas; Mitchell B Max
Journal:  Mol Pain       Date:  2007-07-26       Impact factor: 3.395

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.